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The Xenopus egg has a yolk-laden vegetal hemisphere juxtaposed to a darkly pigmented animal hemisphere. Mesoderm is derived from the
marginal zone, located at the interface between the two hemispheres. The vegetal-most cells become endoderm and release TGF-β-related factors,
including the Xenopus Nodal related (Xnr) proteins, which diffuse to induce the marginal zone to form mesoderm. The remaining animal cells
become ectoderm, but our understanding of the mechanisms that limit the response to induction is incomplete. In this study, we provide evidence
to suggest that Xrel3, a member of the Rel/NF-κB family, plays a role in defining the boundary separating induced from uninduced cells by
regulating Xnr-responsive gene transcription. Ectopic Xrel3 expressed in prospective mesoderm caused repression of mesoderm-specific genes
resulting in loss-of-function phenotypes that were rescued by co-expression of Xnr2. Depletion of Xrel3 from embryos with antisense
morpholinos increased Xnr-dependent transcription, broadened expression of the pan-mesoderm marker Xbra and sensitized animal cells to
mesoderm induction by Xnr2. We propose that an additional component to the mechanism that differentiates the ectoderm from the mesoderm
involves regulation of nodal-dependent gene transcription by Xrel3.
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The specification of the primary germ layers in the Xeno-
pus embryo requires temporally and spatially coordinated
expression and regulation of transcription factors and
intracellular signaling molecules (Fukuda and Kikuchi, 2005;
Sinner et al., 2006; Heasman, 2006). The maternally derived
T-box transcription factor, VegT, is concentrated at the vegetal
pole (Zhang and King, 1996; Zhang et al., 1998; Bubunenko
et al., 2002) and activates members of the Transforming
Growth Factor (TGF)-β superfamily of secreted factors. This
important class of diffusible differentiation factors include the
embryonic Xenopus nodal-related (Xnr) proteins and Activin⁎ Corresponding author. Division of Biomedical Sciences, Faculty of
Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive,
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doi:10.1016/j.ydbio.2007.08.040B, which are implicated in anterodorsal mesoderm induction
(Jones et al., 1995; Jones and Smith, 1995; Osada and Wright,
1999; Agius et al., 2000; Takahashi et al., 2000; Rex et al.,
2002), and Derrière, which is required for ventral mesoderm
differentiation (Kofron et al., 1999). None of these factors are
expressed in the animal pole cells, which are fated to become
ectoderm.
Signaling by Nodals occurs by the SMAD-dependent
transduction mechanism in cooperation with other factors,
including forkhead activin signal transduction (Fast)-1 (also
known as FoxH1) and -3 (Chen et al., 1997; Hoodless et al.,
1999; Watanabe and Whitman, 1999; Yeo et al., 1999; Germain
et al., 2000; Kofron et al., 2004). These winged helix domain
containing transcription factors bind in a sequence specific
manner to the Activin Response Element (ARE) in the
promoters of genes encoding factors that are required to pattern
the embryonic mesoderm.
Members of the Xnr family are essential for patterning the
mesendoderm of the early embryo (Jones et al., 1995; Osadac. All rights reserved.
Table 1
Oligonucleotide primers used for polymerase chain reactions
Primer name Sequence (5′→3′)
Histone H4* U-CGGGATAACATTCAGGGTATCACT
D-ATCCATGGCGGTAACTGTCTT
Xrel3 U-CAAGAGAGACGTGAACCAATTCC
D-GGCGCTGCTGTTGGTGCTGTGC
Xbra U-GGATCGTTATCACCTCTG
D-GTGTAGTCTGTAGCAGCA
VegT U-CAAGTAAATGTGAGAAACCGTG
D-CAAATACACACACATTTCCCGA
Endodermin U-TATTCTGACTCCTGAAGGTG
D-GAGAACTGCCCATGTGCCTC
Xnr1 U-GTAGGAGAGTGGACATGATTGTGG
D-TTAACTGCACCCACATTCCTCTACAATC
Xnr2 U-CGCCATTGCCTCCCTTATGC
D-CAGATTCTTGCAGGACGGG
Xnr5 U-CCAGAACAGCATCATAAGAAGCGG
D-GGCTTGAAGTTCTCATCCAGTGG
Xnr6 U-CCACACCAAAGACCGTCACGAG
D-CCAACATGACTCTCTCCGCAAC
mix2 U-TGCAAGCCATCATTATTCTAGC
D-AGGAACCTCTGCCTCGAGACAT
Goosecoid U-GTGCTGATTCCACCAGTGCCTCACC
D-CAACTGTCAGAGTCCAGGTCAG
Derrière U-CATCTCCACTTACCTTCCAGG
D-CCTTGATCTCGATATGAGCGGAC
Xvent1 U-GCTTGGTTCCTCCTCCCGTC
D-CATGGTGGTGGAGTGGCTGG
Xvent2 U-CCATCCCTGCCTTCCTGGAAC
D-CCTGTGTAGCAATCCATTGTCTCC
Ectodermin U-ATGGCGGATAACAAAGGAGGAGG
D-CTCTGCCGGGGTATCTGTAG
Xsox2 U-GAGGATGGACACTTATGCCCA
D-CCATTGATCCCTGTGCCCGCTA
Xema U-GCCCACAAGCACATTCTCCACCACGCT
D-GCTAGCTGCCTCTGCATCCCATCTG
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These inducers act at a distance from where they are secreted,
capable of diffusing rapidly through the extracellular spaces
within the large amphibian embryo (Williams et al., 2004; Cha
et al., 2006). A number of extracellular and intracellular factors
exist to prevent abnormal ectopic induction of animal cells,
thereby distinguishing the mesoderm germ layer from the
ectoderm (Kurth et al., 2005; Cha et al., 2006). Active
repression of the pan-mesodermal gene Xbrachyury (Xbra) in
the ectoderm and endoderm, for example, restricts its expres-
sion to the prospective mesoderm (Lerchner et al., 2000). Two
recently discovered intracellular regulators that are required to
maintain the mesodermal–ectodermal boundary of the blastula
include the transcription factor Xema (Suri et al., 2005), a
member of the foxi winged-helix domain-containing proteins
and ectodermin (Dupont et al., 2005), which binds to and
ubiquitinates SMAD4, targeting it for proteosomal degradation.
In addition to these examples of intracellular modulators of
mesoderm induction, it is possible that other factors might
exist.
The Rel/NF-κB transcriptional regulators are an important
family of proteins that are involved in cell differentiation
events both in the embryo (Kabrun and Enrietto, 1994;
Prothmann et al., 2006) as well as in disease such as cancer
(Karin, 2006). While much has been documented on the
biological roles of Rel/NF-κB proteins, their mechanisms of
action are dependent on cell context where they can both
repress and activate gene transcription (Perkins, 2004; Camp-
bell and Perkins, 2006). We previously demonstrated that
Xrel3, a Xenopus member of the Rel/NF-κB family, is
expressed in embryos in a temporally and spatially regulated
manner. Xrel3 transcripts are localized to animal and marginal
zone cells in the blastula stage embryo, are absent at
gastrulation, but are then re-expressed in the anterior develop-
ing nervous system (Yang et al., 1998).
The pattern of expression of Xrel3 suggested that it has
differential roles in the embryo at different times of develop-
ment. We previously found that overexpression of Xrel3 in the
animal hemisphere of embryos promoted ectodermal growth
and that it was necessary for head development and expression
of head and neurectoderm-specific genes (Lake et al., 2001).
Here, we present evidence suggesting that in the pre-gastrula
embryo, Xrel3 acts as a factor to regulate the competence of
animal cells to Xnr-mediated induction by limiting their
response to Xnr-mediated signaling. These results provide an
additional component to the mechanism that defines the primary
germ layers.
Materials and methods
Synthetic RNA and morpholinos
Plasmids containing Xnr2 cDNA were received as gifts from Dr. Janet
Heasman, Derriere from Hazel Sive and pCS2+ GFP from Dave Turner.
Synthetic RNA was made from linearized templates encoding Xnr2, Xrel3,
Derriere, myc-tagged Xrel3 and XrelA and in vitro translated in the presence of
35S-methionine (Amersham) using rabbit reticulocyte cell-free extract (Pro-
mega) as described (Lake et al., 2001). Equal amounts of translation mix wereseparated on SDS–PAGE and the dried gel exposed to film overnight. Western
(immuno) blotting was performed as described previously for embryos (Lake et
al., 2001) using the 9E10 monoclonal antibody against human myc-tag epitope.
Synthetic mRNAwas microinjected into embryos at the 2-cell stage as described
(Lake et al., 2001). Antisense morpholino oligonucleotides (Genetools, LLC)
were designed to complement the start of translation of Xrel3, overlapping 5
nucleotides from the start of translation. The sequence of the Xrel3 MO is 3′-
CCGGCCATGTTGATGAGGTCAGTGT-5′. The control morpholino was a
random sequence, designed by Genetools, of equal length to the Xrel3
morpholino. Morpholinos were handled as recommended by Genetools.
Embryonic manipulation and marker expression analysis
Embryos were obtained by in vitro fertilization (Lake et al., 2001) and
staged according to Nieuwkoop and Faber (“Normal Table of Xenopus laevis”,
Garland Pub., 1994). Total RNAwas extracted and purified from embryos and
animal caps at stage 10 using the Nucleospin RNA isolation kit (Clontech).
Reverse transcription of mRNA to cDNA using random oligonucleotides was
performed as described (Lake et al., 2001). Analysis of cDNAs was performed
using PCR. Oligonucleotide primer sequences for markers are shown in Table 1.
For analysis on ethidium bromide-stained agarose gels, the cycling parameters
were as described for Mix2, goosecoid, Xnr1 and Xbra (Xanthos et al., 2001)
and for histone and Xrel3 (Lake et al., 2001). For real-time PCR, cDNA was
extracted once in phenol:chloroform:isoamyl alcohol (25:24:1), precipitated
overnight at −20 °C with 0.1× ammonium acetate and 2.5× ethanol and
resuspended in H2O at the same volume as original reverse transcription
reaction. Relative gene expression was assayed by real-time RT-PCR (ABI
Prism 7000 Sequence Detection System) using SYBR Green (Applied
Fig. 1. Ectopic Xrel3 overexpression in the marginal zone at gastrulation inhibits
Xbra expression and prevents involution. Embryos were injected with Xrel3
RNA at the two-cell stage and assayed at early gastrula for the expression of
Xbra. Whole mount in situ hybridization analysis was done to stain both
Xrel3 and Xbra messages. Because Xrel3 is expressed at a very low level at
gastrulation the turquoise staining seen in these embryos represents over-
expressed, exogenous Xrel3 RNA. (A) Localization of Xrel3 to the animal pole
(white arrow) does not affect Xbra expression (purple stain), shown also in
panel B and this does not affect bottle cell formation (D, black arrow in panel
B) or axis formation. (F) Injection in the lateral marginal zone resulted in
exclusion of Xbra expression, (C) localized inhibition of bottle cell formation
(arrow in panel E) and localized defects in yolk incorporation (arrow in panel G).
vp—vegetal pole, d—dorsal. Scale bar=0.5 mm.
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72 °C for 30 s. Real-time PCR results were analyzed using the 2−ΔΔCt method
(Livak and Schmittgen, 2001). Markers were normalized against Histone H4
levels and compared to uninjected control embryos. RT negative reactions failed
to give any/specific amplification products.
Whole mount in situ hybridization using maleic acid buffer was performed
as described (Lake et al., 2001) adapted for two color detection methods for the
simultaneous analysis of Xrel3 and Xbra mRNA. Digoxigenin-linked UTP and
fluorescein-linked UTP (Boerhinger) were used to differentially label Xrel3 and
Xbra RNA probes and stained as described (Matsuo-Takasaki et al., 2005).
Reporter transcription assays
A firefly luciferase reporter construct (50 pg) containing intron 1 of the Xnr-
1 gene (referred to as pInt-1-luc), a gift from Dr. Christopher Wright, was
injected or co-injected with either synthetic RNA or morpholinos into the animal
half of embryos at the 2 cell stage. Pools of embryos were collected in triplicate
at stage 10.5 (early gastrula). Transcription assays were performed using the
Luciferase Assay System (Promega). Embryos were homogenized in 200 μl of
1× cell culture lysis reagent (kit reagent) by vigorous vortexing and cleared by
microcentrifugation for 2 min. The supernatant (20 μl) was assayed in 100 μl of
assay mixture and luciferase activity was measured for 10 s with a luminometer.
The pNF-κB-luc reporter plasmid was obtained from Stratagene.
Animal cap elongation experiments
Animal caps were dissected from stage 8 embryos and exposed to
recombinant human Activin A (R&D systems) or recombinant human basic
fibroblast growth factor (R&D systems) with 0.1% bovine serum albumin in
50% Normal Amphibian Medium (NAM). For morpholino experiments,
embryos were injected in both cells of the animal pole at the 2-cell stage with
synthetic mRNAs and/or morpholinos. Animal caps were removed using
Dumont forceps at stage 8 and cultured to stage 10 in 50% NAM or cocultured
by making sandwich explants. The extent of elongation was measured as
follows: no elongation, no protrusion visible and shape was spherical; partial
elongation, asymmetrical in shape with a longer axis in one direction; and full
elongation, significant elongation of explant.Results
Ectopic Xrel3 overexpression in the marginal zone inhibits
gastrulation and expression of Xbra
We previously demonstrated that when Xrel3 was over-
expressed in the animal pole, it caused the formation of
ectodermal tumors but generally did not affect gastrulation or
axis patterning (Yang et al., 1998; Lake et al., 2001). When we
injected Xrel3 into the marginal zone (prospective mesoderm),
however, the embryos developed severe axial defects related to
gastrulation. Synthetic Xrel3 RNAwas injected into embryos at
various positions at the 2-cell stage and assayed by whole
mount in situ hybridization at the gastrula stage for the
expression of Xbra, an early indicator of commitment to the
mesodermal lineage required for the morphogenetic movements
of gastrulation (Conlon and Smith, 1999). Injection of 62.5 pg
of Xrel3 in the animal pole of embryos did not affect the ring-
like expression of Xbra in the marginal zone (n=21)
demarcating the prospective mesoderm at early gastrula (stage
10) (Figs. 1A, B, dark purple staining). A cohort of embryos
(n=36) injected similarly were allowed to develop and
observed for abnormalities. These embryos gastrulated nor-
mally (Figs. 1D, F).In embryos injected with 62.5 pg of Xrel3 mRNA at the
equator, excess Xrel3 RNA became localized to the marginal
zone at gastrulation (Fig. 1C, turquoise staining), which
precluded the expression of Xbra, disrupting its normal ring-
like pattern (100%, n=27, Fig. 1C). The majority of embryos
injected at the marginal zone (87%, n=25) and allowed to
develop to the neurula stage failed to form a complete
blastopore lip (Fig. 1E) and as a result did not incorporate
yolk in a region localized around the injection site (Fig. 1G).
These observations demonstrated that Xrel3 prevented expres-
sion of Xbra and resulted in gastrulation defects.
Xrel3 prevents mesoderm gene expression
We next asked which genes involved in body axis
development were affected by overexpression of Xrel3 in
early embryos. From our initial experiments, we expected that
Activin-induced genes like Xbra may be downregulated by
Xrel3 in the embryo. Xrel3 mRNA was injected at the
animal–vegetal pigment boundary in both cells of two-cell
embryos. The embryos were assayed for the expression of
specific mesendoderm markers at stage 10, a time during
which Xrel3 is not expressed or expressed at low levels (Yang
et al., 1998), to assess the effect of Xrel3 ectopic expression
during gastrulation.
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assayed using real-time PCR. The relative levels of mRNA
corresponding to each of these markers were compared between
embryos injected with a control mRNA (Kao and Lockwood,
1996) and embryos injected with 500 pg and 1.0 ng of Xrel3
RNA (Fig. 2). These dosages resulted in the level of Xrel3
mRNA at stage 10 being approximately 1.5 and 3.0 times the
level of Xrel3 mRNA in the control embryos. These analyses
were performed at least twice using pools of 10–12 embryos per
treatment from independent batches of eggs. For instance, Fig. 3
demonstrates a representative example of an experiment using
total RNA extracted from 12 pooled embryos per treatment with
all embryos derived from a single batch of eggs.
Overexpression of Xrel3 resulted in a consistent down-
regulation of expression of Xnr1, Xnr2 and Derriere to less than
40% of the control injected embryos. Xnr5 and Xnr6 were also
reduced but to a much lesser extent (Fig. 2A). As expected,
Xbra and mix.2 were reduced in expression to below 40% ofFig. 2. Xrel3 overexpression in the vegetal hemisphere prevents the expression
of mesoderm-specific genes. Embryos were injected into the marginal zone of
both cells of two-celled embryos with control RNA, or 0.5 and 1.0 ng of Xrel3
RNA and assayed at stage 10 for the expression of markers by real-time PCR
analysis. RNAwas extracted from 10 to 12 embryos per treatment group. Data
were expressed as fold difference from control injected embryos, normalized to
histone levels in relation to mass of injected Xrel3 mRNA.
Fig. 3. Xrel3 prevents Activin but not bFGF-mediated mesoderm induction in
animal caps. (A) Animal caps dissected from blastula-stage embryos. Untreated
(left panel) animal caps and animal caps from embryos injected with 0 pg
(middle panel) or 125 pg (right panel) of Xrel3 mRNA exposed to 67 pg/μl of
recombinant human Activin A were allowed to develop several hours until
gastrulation. (B) Exposure of animal caps from embryos injected with 125 pg of
Xrel3 mRNA to 0, 25 and 67 pg/μl of Activin A at Stage 8 causes reduction of
expression of mesoderm markers Xbra and Mix.2 assessed by RT-PCR. (C)
Animal caps dissected from embryos injected with 1.0 ng Xrel3 respond
similarly to basic (b)FGF as animal caps from uninjected embryos. (D)
Expression of Xbra is unaffected by overexpression of Xrel3 in animal caps
exposed to bFGF. Ten animal caps from each treatment were analyzed for the
expression of Xbra, Xrel3 and Histone. Stage 7 untreated or Xrel3 injected
whole embryos were used as positive controls for Xrel3 expression and negative
controls for Xbra expression, while stage 10 untreated whole embryos were used
as positive controls for Xbra and negative controls for Xrel3.the controls. Goosecoid was also repressed, but only at the
higher concentration of Xrel3 to 80% of the control level. The
ventral mesoderm markers were also reduced at the higher level
Fig. 4. Co-injection of Xnr2 RNA reduces developmental defects caused by
injection of Xrel3 mRNA in the vegetal hemisphere. (A) Control, untreated
embryos at stage 24. (B) Examples of embryos injected with 1.5 ng of Xrel3
mRNA showing significant reduction of axis development. (C) Examples of
embryos co-injected with 1.5 ng of Xrel3 mRNA along with 180 pg of Xnr2
RNA. (D) Examples of embryos co-injected with 1.5 ng of Xrel3 mRNA along
with 450 pg of Xnr2 mRNA. (E) Pooled data for four experiments showing
distribution of defective embryos (open bars) and embryos with rescued
development (solid bars) with increasing dosage of Xnr2.
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(Fig. 2B). We also examined the expression of germ layer
specific markers and found that the endoderm-specific markers
VegT and endodermin and the ectodermal marker ectodermin
were repressed to about 60–40% of the controls in Xrel3
injected embryos. On the other hand, the ectodermal marker
Sox2 was at least unaffected or slightly activated relative to
controls in embryos injected with both 0.5 ng and 1.0 ng Xrel3
(Fig. 2C). These observations indicated that Xrel3 overexpres-
sion in the marginal zone of embryos causes a repression of
some, but not all mesodermal-specific genes.
Xrel3 attenuates induction by Activin but not basic FGF
The inhibition of mesodermal markers by overexpression of
Xrel3 RNA suggested that Xrel3 was interfering with mesoderm
formation. We tested whether Xrel3 could prevent the ability of
Activin, a potent mesoderm inducer and activator of Xbra (Smith
et al., 1991), to induce the elongationmovements associated with
dorsal mesoderm induction. Animal caps were dissected from
blastula-stage embryos injected with Xrel3 mRNA into the
animal pole at the 2-cell stage and incubated with recombinant
human Activin A (Fig. 3A). At stage 11, the uninjected, Activin-
treated explants underwent extensive elongation movements
indicative of dorsal convergent extension, while the Xrel3-
injected animal caps, like the controls, did not elongate.
Expression of the mesodermal markers, Xbra and Mix.2
mRNA, normally induced in animal caps by Activin, was also
significantly reduced at stage 11 by Xrel3 (Fig. 3B).
Because the expression of Xbra is dependent on and can
be activated by fibroblast growth factor (FGF) (Isaacs et al.,
1994; Cornell et al., 1995), we tested whether Xrel3 could
also interfere with FGF-mediated mesoderm induction in
isolated animal caps. Five hundred picograms of Xrel3 was
injected into the animal poles of embryos at the 2 cell stage.
At stage 8 animal caps were removed from the embryos and
exposed to increasing concentrations of basic FGF (bFGF).
Injection of 500 pg Xrel3 mRNA did not prevent elongation
of animal cap explants treated with 125 ng/ml of bFGF (Fig.
3C). Exposure of animal caps to 50, 100 and 125 ng/ml of
bFGF caused the expression of Xbra in both Xrel3 injected
and uninjected animal caps when assayed at stage 10, when
there is minimal endogenous expression of Xrel3. The lack of
an effect on the response of Xrel3 mRNA-injected explants to
bFGF did not support a role for Xrel3 in modulating induction
by bFGF.
Xrel3 RNA-injected embryos are rescued by co-injection of
Xnr2 RNA
The above experiments suggested that Xrel3 attenuated
mesoderm formation by interfering specifically with Xnr-
responsive gene activation. We therefore determined if the
developmental defects caused by overexpression of Xrel3 in the
vegetal hemisphere could be reversed by co-expression of Xnr2
mRNA, which encodes a diffusible, long-range mesoderm
inducer (Williams et al., 2004).In four separate experiments, 90, 180 and 450 pg of Xnr2
mRNA were co-injected in the vegetal hemisphere at the two-
cell stage with 1.5 ng of Xrel3 RNA and assayed for normal or
defective axis development. Embryos injected solely with
1.5 ng of Xrel3 mRNA had obvious reduction in body axis
formation (Fig. 4B), but co-injection with Xnr2 mRNA resulted
in significant restoration of normal development (Figs. 4C–E).
In two experiments where we co-injected 1.5 ng of Xrel3 with
0.5 ng (n=31), 1.0 ng (n=42) and 1.5 ng (n=38) of Derrière
RNA, there was no rescue of the normal phenotype (not shown).
These experiments suggested that Xrel3 and Xnr2 have
antagonistic roles in axis development.
Repression of Xenopus nodal-related transcription by Xrel3
The Rel/NF-κB transcriptional regulators activate or repress
transcription, depending on cellular context. To test whether
Xrel3 attenuates transcriptional responses to Xnr signaling, we
used a transcriptional reporter construct developed previously
(Osada andWright, 1999) in which a luciferase gene is driven by
the upstream regulatory region of intron 1 of Xnr1. Within this
region are Activin Response Elements (ARE), which bind the
Fig. 6. Repression of Rel/NF-κB-dependent reporter transcription by Xnr2. The
Rel/NF-κB-dependent transcriptional reporter pκB-luc was co-injected into 2-
cell stage embryos in the animal (solid bars) or vegetal hemisphere (open bars)
with 500 pg of Xrel3 mRNA and varying concentrations of Xnr2 mRNA.
Transcriptional activation was assayed at stage 10. Data are expressed as fold
induction over reporter activity in the absence of Xrel3 or Xnr2.
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complex with Smads (Watanabe and Whitman, 1999), upon
Xnr-mediated signal transduction. In addition to the Xnr
enhancer, these elements are also found within the Mix.2
promoter which has been shown to be repressed by mammalian
Rel/NF-κB (Nagarajan et al., 2000).
In preliminary experiments, we found that Xenopus Rel/NF-
κB proteins, like the mammalian counterparts, were able to bind
in vitro to the ARE, suggesting that these proteins may act
directly on gene promoters containing this consensus. We
therefore determined the effect of Xrel3 overexpression on the
Xnr-dependent transcriptional reporter in embryos, which
contains the Xnr1 enhancer. Embryos were injected at the 2-
cell stage with the reporter alone or co-injected with varying
amounts of Xnr2 and Xrel3 mRNA and assayed for reporter
expression at stage 10. There was a significant fold increase
over basal reporter expression when 500 pg Xnr2 was injected
in the animal pole, as expected (Fig. 5A). This fold increase in
reporter activation caused by Xnr2 overexpression was
progressively decreased by the additional injection of increasing
amounts of Xrel3 mRNA (Fig. 5A). Taken together, these
results indicate that Xrel3 prevents transcriptional activation
from the Xnr-responsive promoter.
We next tested whether Xrel3 could repress endogenous Xnr
activity. For this experiment, Xrel3, along with the Xnr-
responsive reporter, was injected without Xnr2 mRNA into the
vegetal hemisphere where it would be expected that the majority
of endogenous Nodal signaling occurs in the embryo. Injection
of the reporter alone showed 75-fold activation over back-
ground. This activation was reduced significantly by co-
injection of increasing amounts of Xrel3 mRNA (Fig. 5B).
Because Xrel3 is not normally found in the vegetal hemisphere
(Yang et al., 1998) these results indicated that ectopic Xrel3
expression prevented endogenous Xnr activity.
Repression of NF-κB dependent transcription by Nodal
The repression of transcription from a nodal-responsive
reporter by Xrel3 suggested that Xrel3 prevented mesoderm-
specific gene expression by interfering with nodal-dependent
transcription. However, the observation that Xnr2 co-injectionFig. 5. Repression by Xrel3 of induced Xnr-dependent reporter transcription. (A) Th
stage embryos in the animal pole with 500 pg of Xnr2 mRNA (to induce expressio
transcriptional activation at stage 10. Data are expressed as fold induction over the
injected with varying concentrations of Xrel3 in the vegetal hemisphere and assayed
activity in embryos injected with the reporter alone (control).rescued embryos injected with Xrel3 suggested that nodal
activity might also attenuate the activity of Xrel3. We therefore
determined, conversely, the effect of Xnr2 mRNA injection on
expression of the luciferase reporter under the control of a κB
consensus (pκB-luc).
Co-injection of 500 pg of Xrel3 with the pκB-luc reporter
resulted in over 3000-fold activation of the reporter over
background in animal cells and an activation, to a lesser extent
of about 2000-fold when injected into the vegetal pole (Fig. 6).
Co-injection of increasing amounts of Xnr2 RNA from 50 to
500 pg caused significant inhibition of reporter activation in
animal cells (Fig. 6). The activation of pκB-luc in vegetal cells
was lower than in animal cells suggesting that there may be
additive repressive effects of both exogenous and endogenous
Xnr2 activity on κB-dependent transcription in the vegetal
hemisphere. These results suggest that Xnr2 activity is
antagonistic to Xrel3 in embryos by attenuating κB-dependent
target gene transcription. They also indicate that Xrel3 is likely
not a general transcriptional repressor because it acts as a strong
κB-dependent transcriptional activator in the absence of Xnr2.
Xenopus nodal-dependent reporter transcription is derepressed
by injection of Xrel3 morpholinos
Our results so far suggested that Xrel3 activity in animal
cells might be involved in repressing the expression of Nodal-e nodal-dependent transcriptional reporter pInt-1-luc was co-injected into 2-cell
n of the reporter) and varying concentrations of Xrel3 mRNA and assayed for
activity in embryos injected with reporter alone (control). (B) pInt-luc was co-
for reporter expression at stage 10. Data are expressed as fold induction over the
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embryonic development, we designed an antisense morpholino
against Xrel3 (MOxr3). This morpholino was complementary
to the 5′ untranslated region of Xrel3 overlapping the start of
translation by about 5 nucleotides. To first assess the
specificity of MOxr3, we determined whether it could reduce
the in vitro translation of Xrel3. At 300 nM and 600 nM the
level of Xrel3 protein in vitro translated from a cDNA
corresponding to full-length Xrel3 mRNA was reduced
significantly but did not affect translation of a cDNA
corresponding to the NF-κB-p65 Xenopus homolog, XrelA,
when compared to the control morpholino (Fig. 7A). We
further demonstrated the in vivo specificity of MOxr3 with
synthetic mRNA encoding a fusion protein consisting of a
human Myc epitope fused to the start of translation of Xrel3
(mtXrel3). Because MOxr3 was complementary to the 5′-
untranslated region of endogenous Xrel3 mRNA, it did not
inhibit translation of the fusion protein in embryos, as
indicated by immunoblot analysis (Fig. 7B).
The specificity of MOxr3 was confirmed in rescue
assays. Since translation of mtXrel3 RNA was unaffected
by either morpholino at 9.2 ng, we used it to rescue
embryos injected with MOxr3. FITC conjugated (green
fluorescent) control morpholino and Lissamine conjugated
(red fluorescent) MOxr3 were used to monitor their presence
in embryos throughout these experiments. Injection of
9.2 ng of control morpholino into the animal hemisphere
of 2-celled embryos did not affect development (Fig. 7C)
while 4.6 ng of MOxr3 caused mild defects including bent
dorsal axes and minor head defects (Fig. 7D). Embryos
injected with 9.2 ng of MOxr3 completed gastrulation, but
eventually exhibited lack of somites, kinked body axes and
failure of head formation (Fig. 7E). Embryos co-injected
with 9.2 ng of MOxr3 and 0.5 ng of mtXrel3 RNA showed
significant improvement in development as compared to
embryos injected with 9.2 ng of MOxr3 only (Figs. 7F, G).
All embryos, including those injected only with MOxr3
(Figs. 7H, I), control morpholino (Fig. 7J) and MOxr3-
injected ones rescued by co-injection of mtXrel3 RNA (Fig.
7K), contained significant amounts of morpholino in head
and dorsal body axis tissues, as demonstrated by fluores-
cence above background. Thus, MOxr3 was clearly specific
for Xrel3.
To test the hypothesis that endogenous Xrel3 inhibits Nodal
activity in animal cells of the blastula, we depleted
endogenous Xrel3 by co-injecting MOxr3 into the animal
hemisphere of 2-cell stage embryos along with the pInt1-luc
reporter plasmid at the 2-cell stage. We then assessed its effect
on the activation of the reporter at various times following
injection. The activation of the reporter in MOxr3-injected
embryos occurred at about 8.5 h or at stage 8 following
fertilization and increased steadily through gastrulation, at
which time it was induced by over three-fold (Fig. 8) as
compared to embryos injected with the control morpholino.
These findings suggested that depletion of Xrel3 in the animal
hemisphere resulted in ectopic activation of nodal-dependent
transcriptional activation.Depletion of Xrel3 in the animal hemisphere upregulates
Xnr-responsive genes in the late blastula
We next determined whether knockdown of Xrel3 in the
animal hemisphere increased expression of nodal-dependent
genes in animal cells. Animal caps were excised at stage 9 from
embryos injected with MOxr3 at the 2-cell stage. We isolated
animal caps at stage 9, as this was the stage at which there was
an observed induction of Xnr-dependent signaling over
endogenous levels when MOxr3 was injected into the animal
hemisphere (Fig. 8). Explanted animal caps were allowed to
develop to stage 10 and assayed for the expression of Xnr1,
Goosecoid and Xbra. These experiments were performed in
triplicate on ten animal caps each, and in each instance, all three
markers were expressed in the animal caps of embryos injected
with MOxr3, but not in animal caps from control morpholino-
injected or uninjected embryos. There was an approximate 10%
activation of Xnr1 and 12% activation of goosecoid but a
greater than 75% activation of Xbra in MOxr3-injected embryos
as compared to whole embryos (Fig. 9A).
The ectopic expression of mesoderm markers in animal
cells was confirmed using whole mount in situ hybridization
to assay Xbra mRNA spatial expression at stage 10. In the
control morpholino-injected embryos Xbra mRNA was
expressed in its normal ring-like pattern (Figs. 9B, C) in
the marginal zone (n=21) while in embryos injected with
MOxr3 (n=18), the domain of Xbra mRNA expression was
expanded to include the entire animal hemisphere (Figs. 9D,
E). These results indicated that depletion of Xrel3 caused
abnormal Xbra gene expression in the animal hemisphere and
suggested that at least one function of endogenous Xrel3 in
the blastula is to prevent ectopic mesoderm induction in the
prospective ectoderm.
Depletion of Xrel3 in the animal hemisphere is not sufficient to
activate mesoderm marker expression in early blastula cells
Derepression of the Xnr-dependent reporter by MOxr3 was
initiated at stage 8, and isolation of animal caps from MOxr3-
injected embryos at stage 9 showed that they ectopically
expressed mesodermal markers. The activation of these
markers could be due to derepression of Xnr-dependent
expression or derepression of Xnrs themselves. To test this
possibility, we determined if Xrel3-depleted animal cells,
when isolated at an early stage before they received an
induction stimulus, could “auto-activate” mesodermal markers.
Therefore, unlike the above assay in which we removed
animal caps at stage 9 (Fig. 9A), in these experiments, we
removed animal caps at stage 8 because it was at this stage
that the Xnr-dependent reporter was not significantly respon-
sive to MOxr3 (Fig. 8). We isolated animal caps from control
and MOxr3-injected embryos at stage 8 and allowed them to
develop to stage 10, when they were assayed for expression of
Xbra and Xnr1. As with our rescue assay, we monitored
presence of morpholinos to make certain they were present in
the isolated animal caps (Figs. 9F and G). Using more
sensitive real-time PCR, we revealed about 10–12% activation
Fig. 7. Xrel3 antisense morpholinos (MOxr3) that target the 5′ untranslated regions (UTR) of Xrel3 are specific for Xrel3. (A) Autoradiograph of in vitro translation
products in the presence of MOxr3. One nanogram of Xrel3 or XrelA in vitro transcribed RNAwas added to rabbit reticulocyte cell-free translation reaction mix with
the indicated amounts of morpholinos. (B) Myc-tagged Xrel3 (mtXrel3) RNA lacking the 5′-UTR is not affected by MOxr3 when injected into embryos. Ten embryos
were co-injected at the 2-cell stage with 9.2 ng of control morpholinos or MOxr3 along with increasing amounts of mtXrel3 mRNA and assayed for expression of
mtXrel3 protein at stage 9 (late blastula) by western blotting. Tubulin was used as a loading control. (C) Embryos at stage 27 injected 9.2 ng of control morpholino
develop normally. (D) Embryos injected with 4.6 ng of MOxr3 develop slight developmental abnormalities, including bent body axes and minor head defects, if any.
(E) Embryos injected with 9.2 ng of MOxr3 develop extreme defects in body axis development and lack head structures. (F) Rescue of embryos from defects caused by
injection of 9.2 ng of MOxr3 by co-injection with and 0.5 ng of synthetic myc-tagged Xrel3. (G) Decrease in the frequency of developmental defects caused by
injection of MOxr3 by co-injection with myc-tagged Xrel3 mRNA. The data are pooled from two independent experiments using embryos from two different females.
Open bars indicate normal embryos, gray bars indicate mild defects which included normal head and dorsal development but with kinked axes and black bars represent
severe defects, as in panel E. (H) Visualization of Lissamine-conjugated (red fluorescence) MOxr3 in embryos at stage 27. Embryos were injected at the 2-cell stage
with 9.2 ng MOxr3. (I) Visualization of Lissamine-conjugated (red fluorescence) MOxr3 in embryos at stage 27. Embryos were injected at the 2-cell stage with 4.6 ng
MOxr3. (J) Visualization of FITC-conjugated (green fluorescence) control morpholinos in an embryo at stage 27. Embryo was injected at the 2-cell stage with 9.2 ng
control morpholino. (K) Visualization of Lissamine-conjugated (red fluorescence) MOxr3 in an embryo at stage 27. Embryo was injected at the 2-cell stage with 9.2 ng
MOxr3 and 0.5 ng of myc-tagged Xrel3 synthetic mRNA. (L) Uninjected embryo at stage 27 visualized under fluorescence optimized for FITC to reveal background
autofluorescence. (M) Uninjected embryo at stage 27 visualized under fluorescence optimized for Lissamine to reveal background autofluorescence.
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removed at stage 9 but less than 10% activation of Xbra in
animal caps, relative to whole embryos with both 5 and 10 ng
of MOxr3. Thus, MOxr3 did not increase the endogenous
level of Xnr1 in animal caps isolated at stage 8 and there was
only a slight increase in Xbra expression.The low level of animal expression of Xnr1 we observed was
endogenous expression independent of mesoderm induction
and presence of Xrel3. Thus, depletion of Xrel3 from the animal
hemisphere at the early blastula stage was insufficient to
derepress endogenous mesoderm marker expression. On the
other hand, the expression of Xbra in Xrel3-depleted animal
Fig. 8. Depletion of Xrel3 in embryos causes ectopic activation of Xnr-dependent
reporter transcription. Embryos were co-injected with 9.2 ng of MOxr3 (n=20,
triangles) or control morpholino (n=20, rectangles) along with the Xnr-
dependent pInt-1-luc reporter into the animal poles of embryos at the 2-cell stage
and assayed for reporter expression at various times following fertilization. Data
are expressed as fold induction (increase) of transcriptional activation over
background activation in embryos injected with reporter alone (n=20).
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dissected at stage 9, reflecting a true response to depletion of
Xrel3. This finding strengthens the conclusion that Xrel3 more
likely regulates the response to induction rather than repressing
Xnr transcription directly.
Xrel3 depleted animal caps are sensitized to mesoderm
induction by Xnr2
The above experiments suggested that, in the absence of
Xrel3, animal cells lost their ability to control their competenceFig. 9. Depletion of Xrel3 causes ectopic activation of mesoderm-specific genes in p
Embryoswere injectedwith 9.2 ng of controlmorpholino orMOxr3 at the two-cell stag
to stage 10, when they were analyzed for the expression of mesodermal markers using
Xnr1 specific oligos run on a 8.0% TBE–agarose gel and stained with ethidium bro
embryos of 2 females. (B) Embryo injected at the animal pole with control morpholin
zone, indicative of normal mesoderm specification. (C) Bisected view of embryo in
expression of Xbra throughout animal hemisphere. (E) Bisected view of embryo in p
animal caps assayed for mesoderm markers. (G) Verification of MOxr3 detected as red
animal caps show little or no autoinduction of Xbra and Xnr1. Real-time PCR results o
from embryos injected with MOxr3 and assayed at stage 10. Data represent relative am
Xenopus Nodal 1 (Xnr1). Data were normalized first to histone as a loading controlto respond to mesoderm induction. Thus, we predicted that
animal cells injected with MOxr3 should respond more readily
to induction stimuli. Consequently, we tested whether Xrel3 was
required to regulate elongation of mesoderm-induced animal
caps, the convergent extension (CE) movements indicative of
mesodermal differentiation (Winklbauer et al., 1996).
MOxr3 did not significantly activate the expression of Xnr1
in animal caps that were removed at stage 8, suggesting that
Xrel3 did not solely transcriptionally regulate expression of
Xnr1. It was possible, therefore, to test the ability for
MOxr3 to modulate the response of uninduced animal cells
to induction signals. For these experiments, 9.2 ng of MOxr3
or control morpholino was co-injected with varying concen-
trations of synthetic Xnr2 mRNA into the animal hemispheres
of embryos at the 2-cell stage. Injection of 9.2 ng of MOxr3
alone did not induce CE when compared to control
morpholino-injected animal caps, but with increasing amounts
of co-injected Xnr2 RNA, there was a significant increase in
CE as judged by elongation of explants as compared to
embryos co-injected with Xnr2 and the control morpholino
(Fig. 10A). Thus, depletion of Xrel3 sensitized the response of
animal cells to Xnr1. Since injection of MOxr3 alone did not
significantly induce CE, these results support the hypothesis
that simple repression of Xrel3 alone cannot induce meso-
dermal fate.
The sensitization of MOxr3-injected animal caps to Xnr2
suggested that Xrel3 normally attenuates mesoderm induction.
Because the Xnr2 mRNA was co-injected with MOxr3, this
experiment did not distinguish whether the response is a cell-rospective ectoderm. (A) MOxr3 causes ectopic expression of Xbra at stage 10.
e in the animal pole. Animal caps were removed at stage 9 and allowed to develop
RT-PCR. Examples shown are amplication products using Xbra, Goosecoid and
mide. These data represent mRNA extracted from 10 animal caps pooled from
o shows normal ring-like expression of Xbra (blue staining) around the marginal
panel B. (D) Embryo injected at the animal pole with MOxr3 shows expanded
anel D. (F) Verification of control morpholino detected as green fluorescence in
fluorescence in animal caps assayed for mesoderm markers. (H) Xrel3-depleted
f Xbra and Xnr1 expression in animal caps. Animal caps were dissected at stage 8
plicon concentration using oligonucleotides specific for Xbrachyury (Xbra) and
and plotted as a percentage of values obtained for the whole embryo.
Fig. 10. Depletion of Xrel3 in animal caps sensitizes them to induction by Xnr2-expressing cells. (A) Animal caps were dissected from embryos co-injected with 10 ng
of control morpholino or MOxr3 along with increasing amounts of Xnr2 mRNA at the two-cell stage and observed for CE as assessed by elongation of explants.
Cumulative data are shown for 27 to 30 embryos pooled from three experiments. Means of percentage of elongated explants was determined and plotted against
concentration of injected Xnr2 mRNA. Vertical bars represent standard deviation. (B) To test whether depletion of Xrel3 sensitized animal cells to induction, animal
caps were dissected from embryos co-injected at the two-cell stage with GFP mRNA and MOxr3 and sandwiched with animal caps dissected from embryos injected at
the 2-cell stage with varying concentrations of Xnr2 mRNA. (C) Examples of sandwich explants at stage 12 composed of animal caps injected with 0, 12.5 and 25 pg
Xnr2 mRNA, respectively, fused to animal caps injected with 10 ng of control or MOxr3-injected (fluorescent) animal caps. (D) Pooled elongation data collected from
three experiments representing 32–40 sandwich explants derived from embryos collected from three batches of eggs. Lower case Roman numerals correspond to
treatment groups shown in panel B. Error bars represent standard deviation.
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extracellular inducing signals. Experiments were performed,
therefore, in which animal caps at stage 8, dissected from
embryos injected with MOxr3 (responding cells), were fused
to animal caps from embryos injected with Xnr2 mRNA
(inducing cells) (Fig. 10B). In this way, we could test whether
MOxr3-injected cells were sensitized to external induction
stimuli. The responding cells were co-injected with mRNA
expressing Green Fluorescent Protein in order to trace their
behavior in relation to the Xnr-injected inducing tissue at the
equivalent early neurula stage (stage 12) (Fig. 10B). The
expression of GFP in cells was unaffected by either the control
morpholino or MOxr3 (Fig. 10C).Animal caps injected with 9.2 ng of either MOxr3 or control
morpholino, when combined with untreated animal caps (0.0 pg
of Xnr2 mRNA), did not elongate. The labeled (morpholino-
injected) cells did not generally mix with unlabeled (untreated)
cells (Fig. 10C, i and iv). This result was consistent in four
experiments with 10–15 explants constructed for either
treatment (Fig. 10D). When animal caps from control
morpholino-injected embryos were combined with animal
caps from embryos injected with 12.5 and 25 pg of Xnr2
mRNA, there was slight elongation of the labeled (control
morpholino-injected) part of the fused explants, and there was
little if any mixing of labeled and unlabeled cells (Fig. 10C, ii
and iii). This slight or partial elongation was consistent in four
393M.W. Kennedy et al. / Developmental Biology 311 (2007) 383–395experiments, with 10–15 explants per experiment, in which
about 20% of the explants elongated partially with 12.5 pg of
Xnr2 RNA and 50% in explants injected with 25 pg Xnr2 RNA
(Fig. 10D).
When animal caps from MOxr3-injected embryos were
fused with animal caps from both 12.5 and 25 pg of Xnr2 RNA-
injected embryos, the fused explants underwent extensive CE
with both labeled (responding, morpholino-injected) and
unlabeled (inducing, Xnr2 RNA-injected) cells contributing to
the elongated structure (Fig. 10C, v and vi). Over 50% of these
fused explants in which 12.5 pg of Xnr2 RNAwas injected and
70% in which 25 pg was injected underwent full elongation
(Fig. 10D).
These experiments demonstrated that animal caps from
Xrel3 injected embryos were more sensitive to induction by
other cells in which Xnr2 was overexpressed. They suggest that
endogenous Xrel3 normally is required to attenuate or restrict
the response of animal cells to external mesoderm induction
signals.
Discussion
We propose that inhibition of Xnr-dependent transcription by
Xrel3, and conversely, Xrel3-dependent transcription by Xnr,
occurs in the blastula embryo to ensure that ectodermal-specific
gene expression is attenuated in prospective mesoderm while
Xnr-dependent gene expression is prevented in prospective
ectoderm. Our results indicated that Xrel3 overexpression
suppressed mesoderm gene expression and Xnr-dependent
reporter transcription suggesting that Xrel3 attenuates Xnr-
mediated mesoderm induction. Furthermore, animal caps from
embryos depleted of Xrel3 did not elongate and only slightly
activated mesoderm markers. Only upon external Xnr-mediated
induction stimulus did these animal caps undergo significant
responses, suggesting that Xrel3 may be responsible to regulate
the competence of animal cells to respond to induction signals.
To assay Xnr-mediated signaling in embryos, we used a
transcriptional reporter under the control of the Xnr1 promoter,
previously demonstrated to be directly responsive to TGF-β
related signaling (Jones et al., 1995). In our experiments,
depletion of Xrel3 from uninduced animal caps did not activate
Xnr1 expression, indicating that simple derepression from the
Xnr1 promoter may not be sufficient for uninduced cells to
activate mesendoderm expression. Only after an induction
stimulus, such as contact with animal cells overexpressing
Xnr2, was a significant induction response noted. Taken
together, our findings suggest that Xrel3 likely acts by
regulating Xnr-mediated signaling rather than directly on
initiation of Xnr expression.
While our results suggest that Xrel3 may be required to
attenuate the response to mesoderm induction, they do not
necessarily implicate a specific mode of inhibition. We note that
although our reporter assays suggest that Xrel3 may bind to and
inhibit or interfere with initiation of transcription from the
reporter plasmid, endogenous suppression is likely far more
complex. In this regard, additional experiments to determine
whether Rel proteins directly interact with DNA bindingelements on target genes or whether they indirectly act by
activating other repressors would be an important first step to
unravel this mechanism. Whether or not the overexpression (or
depletion) of Xrel3 in embryos causes an immediate early
response to mesoderm induction, for instance, could be assessed
using inhibitors of protein synthesis. These additional assays do
not alter the primary conclusion of this study but are the subject
of more biochemical aspects of the phenomena we described
herein.
We found that Xrel3 prevented Activin-mediated but not
basic FGF-mediated mesoderm induction. This suggests that
Xrel3 likely represses the initial Nodal-dependent events
associated with early mesoderm formation; the resistance of
FGF-induced tissue to Xrel3 suggests that Xrel3 acts upstream
of FGF-dependent mesoderm determination steps. Recent
evidence has suggested that early mesoderm requires the
activity of the Slug transcription factor and that this activity
actually depends on Rel/NF-κB (Zhang et al., 2006). While the
requirement of Slug in FGF-mediated developmental events has
been demonstrated (Buxton et al., 1997), it is possible that this
recent finding reflects a requirement for slug/NF-κB in FGF-
mediated early mesoderm induction rather than on Nodal
mediated events.
The reciprocal co-repression by Xnr2 and Xrel3 can be
overcome by overexpression of one or the other, suggesting that
maintenance of the differentiation states of mesendoderm and
ectoderm under physiological conditions is dependent on the
intensity of the inducing signal(s). Thus, the boundary
separating prospective ectoderm from the mesoderm and
endoderm may be represented by a spatial signaling threshold.
Our results suggest the possibility that Xrel3 (or other
combinations of Rel/NF-κB factors) may be required to define
the threshold by limiting Nodal-dependent gene activation in
cells of the animal hemisphere. Thus, depletion of Xrel3 in the
animal hemisphere, as we have shown, would result in the
absence of the limiting factor and subsequent abnormal
propagation of the inducing signal to the prospective ectoderm.
Previous studies demonstrating the expression of Rel/NF-κB
in the animal hemisphere and marginal zone (Bearer, 1994;
Yang et al., 1998) are not inconsistent, however, with a role of
Xrel3 in defining the border between induced and uninduced
tissue. Our finding that Xnr2 could actively suppress Xrel3-
dependent reporter expression suggests that Xrel3 activity may
be in competition with Nodal activity at the marginal zone and
that the intersection of the two at some level would be necessary
to define the boundary separating the ectoderm from the
mesendoderm.
Attempts to ascribe a role for Rel/NF-κB proteins in Xeno-
pus utilized variant forms of Rel proteins in embryos
(Richardson et al., 1994; Tannahill and Wardle, 1995; Beck et
al., 1998; Lake et al., 2001), which caused diverse develop-
mental defects. The interpretation of these findings is tempered
by the likelihood that such mutant proteins may interfere with
the function of multiple Rel/NF-κB family members in different
parts of the embryo at different times of development. In the
present study, the gene-specific morpholinos help to clarify the
role of at least one member, Xrel3, but it must be borne in mind
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related family members and that we may not have depleted all
of the maternal Xrel3 protein.
Our finding that Xrel3 depletion in animal caps by
morpholino injection activated both Goosecoid and Xbra gene
expression was not expected since while both genes are
activated in response to mesoderm induction, Goosecoid
normally acts as a repressor of Xbra expression (Latinkic and
Smith, 1999). In addition, we did not see a significant
depression in Goosecoid expression in embryos injected with
Xrel3 in the marginal zone. The simplest explanation for this is
that the distribution of the Xrel3 morpholino (or Xrel3 mRNA)
across the cells of the animal cap may have been uneven,
leading to differential cellular responses. Alternatively Xrel3
may act as a co-factor to repress Xbra expression in conjunction
with Goosecoid. In this regard, Rel/NF-κB proteins may have
complex, pleiotropic roles in development by repressing or
activating target genes in a cell-context-dependent manner. An
important step towards elucidating this possibility will be to
assay for the direct targets of Xrel3 overexpression. Determin-
ing the immediate-early response genes to Xrel3 overexpression
(and depletion) by, for instance DNA microarray analysis, will
prove useful for this purpose. Our results have indicated,
nonetheless, that at least one function for Xrel3 is to modulate
the response to Nodal-mediated mesoderm induction, from
which more detailed analyses such as these can be derived.
The existence of a mechanism of reciprocal co-repression of
transcription by TGFβ factors like Xnr2 and Rel/NF-κB factors
such as Xrel3 is not without precedent in vertebrates. For
instance, the latent membrane protein-1 of Epstein Barr Virus
represses the antiproliferative activity of TGFβ in murine
fibroblasts by activation of NF-κB (Mori et al., 2003) which
subsequently inhibited SMAD-dependent transcriptional activity
of TGFβ. NF-κB also directly inhibits TGF-β mediated
transcription in hepatoma cells and interfered with ARE-
dependent reporter transcription in these cells (Nagarajan et al.,
2000). Finally, TGFβ repression of Matrix Metalloproteinase-1
in human dermal fibroblasts occurred via abrogation of NF-κB-
specific gene transcription (Yuan and Varga, 2001), an example
illustrating the ability of TGFβ to antagonize Rel/NF-κB activity.
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